Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).
Similar Posts
Other | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been granted for supportive care products and changes to dosing or formulation.www.portmeds.com – 711585 – 07/16/2025
Unapproved New Drugs/MisbrandedInnoStar Bio-Tech Nantong Company, Ltd – 11/1/2024
InnoStar Bio-Tech Nantong Company, Ltd – 11/1/2024. Country: United States. Record Type: Response to Form 483Chetak LLC Group Recalls Product Because of Possible Health Risk
Are recalling Frozen ‘Deep Sprouted Mat(Moth) 16 oz. and Deep Sprouted Moong 16oz. because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infection in young children, frail or elderly people and others with weakened immune system.www.buycodeine.us – 702527 – 05/05/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetOffice of Prescription Drug Promotion (OPDP) News
Review the latest news from the Office of Prescription Drug Promotion.
